Shanghai Company Destroys Illegal E-cigarette Products According to Regulation

Regulations by 2FIRSTS.ai
May.29.2024
Shanghai Company Destroys Illegal E-cigarette Products According to Regulation
Shanghai Rowell Technology Co., Ltd. was ordered to correct illegal sales of e-cigarette products and publicly destroy them.

According to information published on the Credit China website, on May 24, 2024, Shanghai Xingyue Zhi Technology Co., Ltd. was ordered by the Minhang District Tobacco Monopoly Bureau of Shanghai to immediately rectify the illegal sale of e-cigarette products, aerosols, and nicotine for e-cigarettes, and publicly destroy the illegally manufactured e-cigarette products.

 

According to information received, on March 8, 2024 at 13:36, law enforcement officers from the Minhang District Tobacco Monopoly Bureau in Shanghai received a report. After presenting their law enforcement credentials, stating their identity, and explaining the purpose of their visit, they lawfully inspected the premises at Room 1, 1st Floor, No. 10, Lane 399, Xinlong Road, Minhang District, Shanghai. The individual in question holds a tobacco monopoly retail license, with permit number: 310112208669.

 

At the site, a total of 5 varieties and 26 boxes of a certain brand of e-cigarette products suspected of illegal activities were found. The above-mentioned e-cigarette products are suspected of being illegally produced. According to the person in charge at the scene, the above-mentioned e-cigarette products were intended for sale. The individuals were found to be selling flavored e-cigarettes other than tobacco flavor and were selling e-cigarette products that do not meet mandatory national standards and have not undergone technical reviews. The packaging labels of the e-cigarette products do not comply with relevant regulations.

 

The punishment is based on the Implementing Regulations of the Tobacco Monopoly Law of the People's Republic of China, Article 25, which states that no individual or entity may sell illegally produced tobacco products. Article 58 of the same regulations stipulates that those who violate Article 25 and Article 38, Paragraph 1, by selling illegally produced tobacco monopoly products, will be ordered to stop sales by the tobacco monopoly administrative authority, confiscate illegal gains, impose a fine of 20% to 50% of the total illegal sales amount, and publicly destroy the illegally sold tobacco monopoly products. In accordance with the "Regulations on the Administration of E-cigarettes," Article 5, Paragraph 1, e-cigarette products must comply with mandatory national standards for e-cigarettes. Article 13 states that e-cigarette products must use registered trademarks and adhere to the regulations for the use and management of tobacco product trademarks. Article 14 requires that e-cigarette products comply with packaging labeling and warning language regulations. Article 19, Paragraph 3, prohibits the sale of e-cigarette products that have not undergone technical evaluation. E-cigarette products on the market for sale must be consistent with the information of products that have passed technical evaluation. Article 26 prohibits the sale of flavored e-cigarettes other than tobacco flavor and e-cigarettes that can add atomizing substances independently.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

FDA Tobacco Center Pushes Review-Efficiency Statement After Commissioner’s Exit
FDA Tobacco Center Pushes Review-Efficiency Statement After Commissioner’s Exit
FDA CTP issued a May 7 statement on accelerating product review and improving PMTA efficiency, but did not push it via official X and newsletter until May 13, one day after FDA Commissioner Marty Makary’s resignation was confirmed. FDA has not explained the delay, and no public evidence links it directly to the leadership change. The timing is notable given CTP’s usual 24-hour distribution practice.
Special Report
May.14
 Zyn Emerges as MAGA Cultural Symbol Amid FDA Policy Shift
Zyn Emerges as MAGA Cultural Symbol Amid FDA Policy Shift
According to The Wall Street Journal, nicotine pouch brand Zyn has rapidly gained popularity across the Trump administration and conservative political circles, including among U.S. Health Secretary Robert F. Kennedy Jr.
Business
May.20
India Seizes $14 Million Worth of Illegal Vaping Products Imported From China
India Seizes $14 Million Worth of Illegal Vaping Products Imported From China
India’s Directorate of Revenue Intelligence (DRI) seized approximately 300,000 illegal e-cigarettes and vaping devices worth more than ₹120 crore (approximately $14 million) during coordinated multi-state enforcement operations.
Regulations
May.22
FDA Commissioner Marty Makary Resigns After Opposing Trump Administration’s Flavored Vape Push
FDA Commissioner Marty Makary Resigns After Opposing Trump Administration’s Flavored Vape Push
FDA Commissioner Marty Makary resigned on May 12 after opposing the Trump administration’s push to authorize fruit-flavored vaping products, according to reporting by The New York Times. Makary reportedly objected over concerns that flavored vapes could attract young people and refused to support broader approvals.
News
May.13
AP Questions FDA Rationale as Glas Fruit-Flavored Vapes Won Authorization Without Added Cessation Benefit
AP Questions FDA Rationale as Glas Fruit-Flavored Vapes Won Authorization Without Added Cessation Benefit
The U.S. Food and Drug Administration (FDA) recently authorized two fruit-flavored vaping products from Glas, but a newly released agency memo shows the products did not demonstrate greater smoking-cessation benefits than tobacco-flavored e-cigarettes. The Associated Press said the findings are likely to raise further questions about the FDA’s regulatory rationale and standards for flavored vaping products.
Jun.12
Trump’s Tobacco Investments and Industry Donations Draw Scrutiny as FDA Eases Vape and Nicotine Pouch Rules
Trump’s Tobacco Investments and Industry Donations Draw Scrutiny as FDA Eases Vape and Nicotine Pouch Rules
A report by KFF Health News says that as the Trump administration pursued a series of policies favorable to the nicotine and tobacco industry, President Donald Trump increased his holdings in tobacco companies while benefiting from substantial industry-linked political donations, prompting questions from public health advocates about potential conflicts of interest and regulatory direction.
Jun.12